The Year in Review

We have had an exciting and productive year on the AHNS Cancer Prevention Service. In the past twelve months, we awarded five Community Service Awards to our members, developed an AHNS position statement on the use of tobacco, E-cigarettes and marijuana, participated in the Inaugural USvsHPV event in January, helped promote the annual Oral and Head and Neck Cancer Awareness Week, and are working on developing a toolkit for head and neck cancer screening and education in homeless populations, among other projects. This year, we have plans to expand on these efforts and will also initiate many new endeavors to promote the early detection and prevention of head and neck cancers.

What’s New?

This photo shows Dr. Cherie-Ann Nathan (President of the AHNS) and Dr. Michael Moore (Chair, Cancer Prevention Service of the AHNS) at the recently held Annual Meeting of the American Cancer Society’s HPV Vaccination Roundtable in Atlanta, GA.  This conference brought together stakeholders from over 70 participating organizations focused on finding ways to increase HPV vaccination rates in America. Sessions were held to highlight best practices in areas including health policy, physician recommendations, and patient and public education. Additional discussions centered around how best to combine the expertise and reach of the member organizations to raise awareness of HPV-related diseases and dispel myths surrounding HPV vaccination.

How Can You Get Involved?

AHNS Members, WE NEED YOUR HELP!  One theme that has consistently come through is the lack of practitioner and public awareness of HPV-related oropharyngeal cancer. It is estimated that there will be approximately 19,000 new cases of HPV-related oropharyngeal cancer in the US this year (www.cdc.gov), making it the most common HIV-related cancer in America. However, unlike cervical cancer, there is no known premalignant precursor of these cancers and we have no effective screening protocol. As a result, these rates are likely to continue to increase, making disease prevention that much more important.

There is currently available on the AHNS Cancer Prevention website a 20-slide presentation on HPV-related oropharyngeal cancer, its associated treatment and the importance of vaccination. Over the next few months, CPS members will be updating these slides and developing a narrated version that can be disseminated by members to their region’s pediatricians and primary care providers. As a part of this initiative, we also hope to provide pre- and post-presentation surveys to perform a gap analysis on these topics to see how best to educate those on the front lines in these vaccination efforts.

Future Projects

The Cancer Prevention Service also has plans to work with the Patient and Public Education Service as well as the Mucosal and Cutaneous Sections to develop lesion libraries to provide visual examples of benign, premalignant and malignant lesions. These resources will then be formatted to best allow them to be distributed to and used by the general public around the time of cancer screening events.

Integrative Medicine

There is an evolving base of knowledge related to the role of integrative medicine in cancer prevention and management. Members of the Cancer Prevention Service will work to update the AHNS members on what is known about integrative medicine in head and neck cancer prevention.

If you have interest in getting involved in these or other projects related head and neck cancer prevention, please contact us at [email protected].  We look forward to working with you.

Sincerely,

Michael Moore, MD
Chair, Cancer Prevention Service

Ann Gillenwater, MD
Co-Chair, Cancer Prevention Service

• Bio
• Latest Posts

Michael Moore

Dr. Michael Moore is the Director of Head and Neck Surgery at Indiana University where he has an active clinical practice in both head and neck cancer and microvascular reconstructive surgery. Dr. Moore also serves as the Chair of the Cancer Prevention Service of the AHNS and is a Board Member of the Head and Neck Cancer Alliance, a not-for-profit devoted to the early detection and prevention of head and neck cancer as well as the support of those affected by the disease.

Latest posts by Michael Moore (see all)

• The AHNS Cancer Prevention Service – Chair’s Report - September 3, 2019

You’re invited…

The American Head and Neck Society in conjunction with the American Academy of Otolaryngology – Head & Neck Surgery are pleased to present the 2019 Head & Neck Surgery Symposium for Residents and Fellows.

Join us for this day-long symposium in New Orleans on Saturday, September 14, 2019. The symposium brings together leading head & neck surgeons, presenting informative lectures on head and neck surgical procedures and treatments. Previous lecture topics have included:

Oral Cancer
Head & Neck Reconstructive Surgery
Pharyngeal Cancer and HPV
Skin Cancer/Melanoma
Neck Dissection/Staging
Parathyroid Surgery
Thyroid Surgery
Salivary Gland
Neoplasm
Sinonasal/Skull Base
Trans Oral Laser Surgery for Head & Neck Cancer
Trans Oral Robotic Surgery
Laryngeal Cancer

The final agenda and faculty lecturers will be announced shortly. Attendees will also learn about fellowship opportunities available from AHNS-accredited programs as well as Society membership information.

The event is free to residents and fellows. A complimentary boxed lunch and a closing reception are included.

RSVP for this event by clicking HERE

The AHNS Journal Club regularly reviews the leading head and neck cancer-related journals, sharing with AHNS members some of the most relevant and important manuscripts, and providing summaries and critiques of the work.

This Issue of the AHNS Journal Club has been compiled and reviewed by  members of the AHNS Clinical Research Service: Eben Rosenthal, MD; Mark Prince, MD; Christopher Fundakowski, MD; Daniel Faden, MD

Click the links below to access the current issue of AHNS Journal Club – to review past issues – CLICK HERE

Multicenter Trial of [¹⁸F]fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.

Lowe VJ, Duan F, Subramaniam RM, Sicks JD, Romanoff J, Bartel T, Yu JQM, Nussenbaum B, Richmon J, Arnold CD, Cognetti D, Stack BC Jr.

 from The Journal of Clinical Oncology, July 2019

Systematic review on location and timing of distant progression in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.

Tiedemann D, Jakobsen KK, von Buchwald C, Grønhøj C.

from Head & Neck, March 2019

Multimodality Treatment of Early-Stage Tonsil Cancer.

Roden DF, Schreiber D, Givi B.

from Otolaryngology – Head Neck Surgery, July 2017

Frameshift events predict anti–PD-1/L1 response in head and neck cancer

Glenn J. Hanna, Patrick Lizotte, Megan Cavanaugh, Frank C. Kuo, Priyanka Shivdasani, Alexander Frieden, Nicole G. Chau, Jonathan D. Schoenfeld, Jochen H. Lorch, Ravindra Uppaluri, Laura E. MacConaill, and Robert I. Haddad

from JCI Insight, February 2018

Announcing the 5^th International Salivary Gland Congress and 1^st Multidisciplinary Salivary Gland Society (MSGS) World Congress

October 25-26, 2019-5^th International Salivary Gland Congress

Preceded by the 3^rd Jefferson Sialendoscopy course October 24, 2019

Background and Historical Development of the Congress: How it all came about.

The 5^th International Salivary Gland Congress, in Philadelphia, has been in the making as early as the 3^rd International Salivary Gland Congress in Geneva, Switzerland in 2012. It will cover inflammatory diseases and neoplasms. The meeting has been endorsed by the AHNS, the AAO-HNS and the European Salivary Gland Society (ESGS). Faculty from 6 continents and over 20 countries will be speaking and/or part of the Senior Faculty Advisory Council. Abstracts are encouraged.

With  less than 3 months away, please consider joining the Multidisciplinary Salivary Gland Society (MSGS) and you will receive a discounted congress registration rate.

More information can be found here: https://oto.med.upenn.edu/wp-content/uploads/sites/25/2019/03/Program-Brochure-5th-International-Salivary-Gland-Congress.pdf

The history of the International Salivary Gland Congresses is fascinating. The first International Salivary Gland Congress was held in Geneva, Switzerland in 2002.  This pioneering event organized under the banner of the ESGS was led by Dr. Pavel Dulguerov as the president of the organizing committee and was hosted by Dr. Dulguerov and Dr. Francis Marchal. It was a multidisciplinary meeting bringing together surgeons, dentists, pathologists, radiologists, immunologists and basic scientists from several continents.

In 2007, the Second International Salivary Gland Congress was held in Pittsburgh and included a post-congress sialendoscopy lab course. Dr. Barry Schaitkin was a course director along with Dr. Francis Marchal. Notable leaders from the American Head and Neck Society included Dr Eugene Myers, Dr. David Eisele, Dr. Ricardo Carrau and Dr. Henry Hoffman. Dr. David Cognetti, Dr. Rohan Walvekar, Dr. Chris Rassekh and Dr. Robert Witt also participated.

The 3^rd International Salivary Gland Congress was again held in Geneva, Switzerland in 2012 and was accompanied by the First International Sialendoscopy Conference. Dr. Boyd Gillespie, a leader in the AHNS, participated in the Sialendoscopy conference. At this time Dr. Chris Rassekh with the support of Dr Bert O’Malley and Dr. Dulguerov raised the possibility of an International Congress in Philadelphia.

A formal proposal was initiated at the Louisiana State University Sialendoscopy course in 2016 at the pre-course Faculty Strategic Planning Meeting with Cook Medical. Dr. Michael Turner supported the proposal at the First Annual Advanced Sialendoscopy course at Mount Sinai University in New York in 2017. A survey was conducted among sialendoscopy experts in the United states between these two meetings.  Several candidate cities were proposed and Philadelphia received the most supporting votes.

Dr. Ehab Hanna played a vital role in bringing the Congress to Philadelphia at the International Federation of Otolaryngology Societies (IFOS) in Paris in June, 2017. The ESGS announced the 4^th International Salivary Gland Congress in Barcelona in October, 2017 as a part of the CEORL-HNS (Congress of European ORL-HNS). Dr. Rassekh and Dr. Witt were speakers at the meeting and at the ESGS business meeting in Barcelona, it was agreed that the next International Meeting would be in Philadelphia. Dr. Rassekh included Dr. David Cognetti and Dr. Robert Witt to be congress co-chairs given their contributions to the field and ties to Philadelphia. The meeting in Barcelona was ultimately deemed the 4^th International Congress. Commitments were established from the leadership of the University of Pennsylvania, Thomas Jefferson University and Christiana Care Health System for sponsorship of the meeting.

Dr. Cognetti has organized the highly successful 1^st and 2^nd Jefferson Sialendoscopy courses. It was determined that the 3^rd course would precede the 5^th International Salivary Gland Congress. The program and faculty were developed. Dr. Dulguerov was selected as international co-chair. The ESGS leadership (Dr. Marchal, Dr. Vincent Vander Poorten and Dr. Davide Lombardi) have provided much needed advice. Numerous faculty from the ESGS (now becoming the Multidisciplinary Salivary Gland Society), the AHNS and the AAO-HNS are involved as faculty speakers, scientific program committee or International Senior Advisory Council. The 5^th International Salivary Gland Congress will be the 1^st Multidisciplinary Salivary Gland Society (MSGS) and heralds the possible development of an International Salivary Gland Society.